Patent application number | Description | Published |
20090264879 | Fluid-Assisted Medical Devices, Systems and Methods - Surgical devices, systems and methods for treating tissue are provided. Also provided are systems for treating tissue and methods of treating tissue. An exemplary surgical device comprises a handle ( | 10-22-2009 |
20120101496 | FLUID-ASSISTED MEDICAL DEVICES, SYSTEMS AND METHODS - An electrosurgical device includes a first electrode tip connected to a first shaft and spaced from a second electrode tip connected to a second shaft. The first electrode tip serves as a first pole, and the second electrode tip serves as a second pole, of a bipolar electrode configuration. A first fluid outlet opening is defined by a distal end of the first shaft and a portion of the first electrode tip. A second fluid outlet opening is defined by a distal end of the second shaft and a portion of the second electrode tip. At least one recess can be formed in an exterior surface of each of the first and the second electrode tips, providing a fluid flow channel for fluid to flow distally along the respective electrode tip. | 04-26-2012 |
20150245864 | FLUID-ASSISTED MEDICAL DEVICES, SYSTEMS AND METHODS - Surgical devices, systems and methods for treating tissue are provided. Also provided are systems for treating tissue and methods of treating tissue. An exemplary surgical device comprises a handle ( | 09-03-2015 |
20150297284 | FLUID-ASSISTED MEDICAL DEVICES, SYSTEMS AND METHODS - Surgical devices, systems and methods for treating tissue are provided. Also provided are systems for treating tissue and methods of treating tissue. An exemplary surgical device comprises a handle ( | 10-22-2015 |
Patent application number | Description | Published |
20110172691 | METHOD AND APPARATUS FOR TISSUE RESECTION - A resection device includes an elongated probe shaft and a tissue resection member disposed at a distal end of the elongated probe shaft. The tissue resection member has a cutting surface configured for being placed in contact with tissue. In one aspect of the invention, at least one ejection port is located adjacent to the cutting surface of the tissue resection member, wherein the at least one ejection port is coupled to a source of a polymerizable hemostasis-promoting material that is delivered to the resection site of interest. In certain embodiments, polymerization of the hemostasis-promoting material may be accelerated by application of heat, radiofrequency energy, or ultra violet light. | 07-14-2011 |
20130158540 | METHOD OF TREATING TISSUE WITH RADIO FREQUENCY VASCULAR ELECTRODE ARRAY - A method of treating a patient is provided. The method comprises delivering an electrically conductive material within a vascular network, wherein the electrically conductive material embolizes in a region of the vascular network to form a vascular electrode array that assumes a geometry of the embolized region of the vascular network. The method may optionally comprise delivering a containment agent within the vascular network proximal to the delivered electrically conductive material to stabilize the vascular electrode array. The method further comprises applying electrical energy (e.g., radio frequency (RF) energy) to the vascular electrode array to therapeutically conduct electrical energy into a region of the targeted tissue adjacent the embolized region of the vascular network. | 06-20-2013 |
20140005659 | Method of Treating Tissue with Radio Frequency Vascular Electrode Array | 01-02-2014 |
20140012288 | INTRODUCTION DEVICES FOR HIGHLY ARTICULATED ROBOTIC PROBES AND METHODS OF PRODUCTION AND USE OF SUCH PROBES - In an introduction assembly for an articulated probe, a feeding mechanism has actuators for controlling the articulated probe. The introduction device is fixed in a positional relationship to the feeding mechanism. The introduction device includes a support member configured to support an articulated probe. A proximal end of the support member has an entrance configured to guide the articulated probe into contact with the support member. A distal end of the support member has an exit configured to guide the articulated probe from the support member into a region of interest. | 01-09-2014 |
20140318299 | STABILIZING APPARATUS FOR HIGHLY ARTICULATED PROBES WITH LINK ARRANGEMENT, METHODS OF FORMATION THEREOF, AND METHODS OF USE THEREOF - An apparatus for driving an articulating probe comprises an elongate probe constructed and arranged to articulate in at least one predetermined degree of motion and to transition from a flexible state to a rigid state, and a force transfer mechanism constructed and arranged to apply a force to the probe. The force is selected from the group consisting of a force that causes probe to articulate in the at least one predetermined degree of motion and a force that causes the probe to transition from the flexible state to the rigid state. The base structure is attached to portion of the force transfer mechanism and the elongate probe; the base structure comprising one or more stabilizing elements constructed and arranged to resist undesired movement of the probe caused by force from the force transfer mechanism. | 10-30-2014 |
Patent application number | Description | Published |
20100179111 | SIGMA-1 RECEPTOR LIGANDS AND METHODS OF USE - The invention provides compounds of formula I and compositions thereof. The invention further provides methods of using the compounds and compositions. The compounds of the invention can provide high affinity binding to sigma-1 receptors in a mammal. The compounds can exhibit selectivity for the sigma-1 receptor over the sigma-2 receptor. The compounds and compositions of the invention can also be used to treat conditions that involve the sigma-1 receptor, such as addiction, cardiovascular conditions, and cancer, for example, cancer of the breast, lung, prostate, ovarian, colorectal, or the CNS. | 07-15-2010 |
20110218223 | TOPICAL VASOCONSTRICTOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY - Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and formulations of topical vasoconstrictors are provided. Methods for the use of such compositions are also provided. | 09-08-2011 |
20120316246 | TOPICAL VASOCONSTRICTOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY - Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and formulations of topical vasoconstrictors are provided. Methods for the use of such compositions are also provided. | 12-13-2012 |
20130102571 | SELECTIVE SIGMA-1 RECEPTOR LIGANDS - The invention provides compounds of the formulas described herein and compositions thereof. The invention further provides methods of using the compounds and compositions. The compounds of the invention can provide high affinity binding to sigma-1 receptors in a mammal. The compounds can exhibit selectivity for the sigma-1 receptor over the sigma-2 receptor. The compounds and compositions of the invention can also be used to treat conditions that involve the sigma-1 receptor, such as addiction, cardiovascular conditions, and cancer, for example, cancer of the breast, lung, prostate, ovarian, colorectal, or the CNS. | 04-25-2013 |